Cologne, Germany

Michael Völker

This inventor holds 1 USPTO granted patent and 1 published patent application and 3 EPO patents. Top assignee: Bayer Consumer Care Ag. Active years: 2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michael Völker. Retrieved from https://idiyas.com/inventor/michael-völker

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2018

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Michael Völker: Innovator in Non-Steroidal Anti-Inflammatory Drugs

Introduction

Michael Völker is a notable inventor based in Köln, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of non-steroidal anti-inflammatory drugs (NSAIDs) for treating coughs. His innovative approach has the potential to improve patient care and treatment outcomes.

Latest Patents

Michael Völker holds 1 patent for his work on non-steroidal anti-inflammatory drugs for cough. His patent focuses on the use of NSAIDs for the treatment of nonproductive cough caused by viruses or bacteria. Additionally, it describes a formulation that combines at least one NSAID with at least one antitussive to effectively treat coughs.

Career Highlights

Throughout his career, Michael has worked with prominent companies such as Bayer Consumer Care AG and Airbus Defence and Space GmbH. His experience in these organizations has allowed him to develop and refine his innovative ideas in the pharmaceutical industry.

Collaborations

Michael has collaborated with talented individuals, including Marianne Petersen-Braun and Chirin Yekrangi-Hartmann. These partnerships have contributed to the advancement of his research and the successful development of his patent.

Conclusion

Michael Völker is a distinguished inventor whose work in non-steroidal anti-inflammatory drugs has the potential to transform cough treatment. His innovative contributions and collaborations highlight his commitment to improving healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…